Thank you very much, both of you, for being here today.
I'm going to start with you, Dr. Shackelford, if that's okay. One of the things you talked about.... I think it's a complex issue. We're really looking at veterans and their need to get the medicine that's going to make their lives so much better. We know, looking at the multiple challenges—and you outlined them very clearly—that finding something that's going to make life something that they're going to stay with us here for is really important, so I appreciate the work that's been done.
You said in your statement that you saw remarkable responses to medical cannabis. You also mentioned meeting and seeing 30,000 patients. First of all, I want to know if those 30,000 patients were all veterans. Also, could you talk about what that remarkable response is?
One of the things I'm trying to get clearer about is whether it's about matching the right type of cannabis with the right patient. How much work is that? What we have right now is that you're allowed to get three grams, and that's dried. One thing that's happening when they're going out to get it, internally within the clinic they're getting it from or the place they're purchasing it from, is that if they're using something else, they're figuring out what the equivalency is. I'm concerned that this isn't really meeting the needs of our veterans.